v3.19.3.a.u2
Redeemable Convertible Preferred Stock, Common Stock, and Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of Redeemable Convertible Preferred Stock by Class
The following table summarizes the redeemable convertible preferred stock outstanding immediately prior to the conversion into common stock, and the rights and preferences of the Company’s respective series preceding the Company’s IPO in May 2019 (in millions, except share amounts which are reflected in thousands and per share amounts):
Series
 
Shares Authorized
 
Shares Issued and Outstanding
 
Per Share Liquidation Preference
 
Aggregate Liquidation Preference
 
Per Share Dividend Per Annum
 
Per Share Initial Conversion Price
 
Carrying Value, Net of Issuance Costs
Seed
 
174,030

 
152,591

 
$
0.00906

 
$
1

 
$
0.00073

 
$
0.00906

 
$
1

A
 
152,053

 
150,427

 
0.09248

 
14

 
0.00584

 
0.07303

 
11

B
 
123,646

 
122,721

 
0.35448

 
44

 
0.02836

 
0.35448

 
43

C-1
 
76,551

 
76,551

 
4.45438

 
341

 
0.28508

 
3.56350

 
273

C-2
 
31,004

 
31,004

 
3.56350

 
110

 
0.22806

 
2.85080

 
62

C-3
 
842

 
842

 
4.45438

 
4

 
0.28508

 
3.56350

 
3

D
 
87,193

 
82,443

 
15.51305

 
1,279

 
1.24105

 
15.51305

 
1,291

E
 
84,504

 
84,140

 
33.31758

 
2,803

 
2.66540

 
33.31758

 
2,793

F
 
25,228

 
21,262

 
39.63858

 
843

 
3.17109

 
39.63858

 
842

G
 
150,188

 
140,619

 
48.77223

 
6,858

 
3.90178

 
48.77223

 
6,858

G-1
 
35,881

 
35,881

 
48.77223

 
1,750

 
3.90178

 
48.77223

 
1,750

G-2
 
5,126

 
5,126

 
48.77223

 
250

 
3.90178

 
48.77223

 
250

 
 
946,246

 
903,607

 
 
 
$
14,297

 
 
 
 
 
$
14,177


Summary of Activity in Restricted Common Stock
The following table summarizes the activity related to the Company’s restricted common stock for the year ended December 31, 2019. For purposes of this table, vested restricted common stock represents the shares for which the service condition had been fulfilled as of December 31, 2019 (in thousands, except per share amounts):
 
 
Number of Shares
 
Weighted-average Grant-Date Fair Value per Share
Unvested restricted common stock as of December 31, 2018
 
898

 
$
34.81

Granted
 

 
$

Vested
 
(621
)
 
$
34.84

Canceled and forfeited
 
(66
)
 
$
34.59

Unvested restricted common stock as of December 31, 2019
 
211

 
$
34.73


Summary of Stock Options and SAR Activity
A summary of stock option and SAR activity for the year ended December 31, 2019 is as follows (in millions, except share amounts which are reflected in thousands, per share amounts, and years):
 
 
SARs Outstanding Number of SARs
 
Options Outstanding Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contractual Life (in years)
 
Aggregate Intrinsic Value
As of December 31, 2018
 
758

 
42,936

 
$
9.22

 
5.74
 
$
1,456

Granted
 
86

 
250

 
$
43.00

 
 
 
 
Exercised
 
(417
)
 
(6,884
)
 
$
2.85

 
 
 
 
Canceled and forfeited
 
(36
)
 
(1,462
)
 
$
33.29

 
 
 
 
Expired

(54
)
 
(39
)
 
$
26.49

 
 
 
 
As of December 31, 2019
 
337

 
34,801

 
$
9.79

 
4.75
 
$
746

Vested and expected to vest as of December 31, 2019
 
203

 
29,585

 
$
4.97

 
4.49
 
$
745

Exercisable as of December 31, 2019
 
203

 
29,585

 
$
4.97

 
4.49
 
$
745

Schedule of Restricted Stock Units Activity
The following table summarizes the activity related to the Company’s RSUs for the year ended December 31, 2019. For purposes of this table, vested RSUs represent the shares for which the service condition had been fulfilled as of December 31, 2019 (in thousands, except per share amounts):
 
 
Number of Shares
 
Weighted-Average
Grant-Date Fair
Value per Share
Unvested and outstanding as of December 31, 2018
 
75,835

 
$
37.20

Granted
 
62,830

 
$
41.55

Vested
 
(36,034
)
 
$
37.87

Canceled and forfeited
 
(17,888
)
 
$
40.53

Unvested and outstanding as of December 31, 2019
 
84,743

 
$
39.82


Schedule of Stock-Based Compensation Expense by Function The following table summarizes total stock-based compensation expense by function for the years ended December 31, 2017, 2018 and 2019 (in millions):
 
 
Year Ended December 31,
 
 
2017
 
2018
 
2019
Operations and support
 
$
30

 
$
15

 
$
454

Sales and marketing
 
9

 
9

 
242

Research and development
 
25

 
65

 
2,958

General and administrative
 
73

 
83

 
942

Total
 
$
137

 
$
172

 
$
4,596


Schedule of Weighted Average Assumptions The fair value of warrants granted during 2017 and 2018 was determined using the Black-Scholes option-pricing model using the weighted-average assumptions in the table below. During 2019, warrants vested were not material and no warrants were granted.
 
 
Year Ended December 31,
 
 
2017
 
2018
Contractual term (in years)
 
2.1

 
1.6

Risk-free interest rate
 
1.8
%
 
2.5
%
Expected volatility
 
28.3
%
 
34.7
%
Expected dividend yield
 
%
 
%

The fair value of stock options and SARs granted was determined using the Black-Scholes option-pricing model with the following weighted-average assumptions:
 
 
Year Ended December 31,
 
 
2017
 
2018
 
2019
Expected term (in years)
 
8.5

 
6.0

 
6.0

Risk-free interest rate
 
2.0
%
 
2.8
%
 
2.2
%
Expected volatility
 
35.9
%
 
32.9
%
 
33.9
%
Expected dividend yield
 
%
 
%
 
%

The fair value of Performance Awards with market-based targets granted was determined using a Monte Carlo model with the following weighted-average assumptions:
 
 
Year Ended December 31,
 
 
2017
 
2018
 
2019
Risk-free interest rate
 
2.1
%
 
2.8
%
 
2.7
%
Expected volatility
 
40.0
%
 
36.9
%
 
39.0
%
Expected dividend yield
 
%
 
%
 
%

Schedule of Common Stock Repurchases The following table represents a summary of common stock repurchased in connection with discrete arrangements with selected current and former employees during the years ended December 31, 2017 and 2018. The common stock shares repurchased for the year ended December 31, 2019 were not material.
 
 
Year Ended December 31,
(In millions, except share amounts which are reflected in thousands, and per share amounts)
 
2017
 
2018
Common stock shares repurchased
 
3,765

 
286

Common stock repurchase cost
 
$
142

 
$
11

Fair value of repurchase recorded as an increase in accumulated deficit
 
$
32

 
$
13

Excess of fair value recorded as stock-based compensation
 
$
13

 
$
1

Price range per common stock share
 
$ 5.00 - $ 41.65
 
$ 36.58 - $ 41.65